Pediatric Neurology
Volume 28, Issue 5 , Pages 360-364 , May 2003

Lamotrigine and valproate: efficacy of co-administration in a pediatric population

  • Sigride Thomé-Souza, M.D.

      Affiliations

    • Laboratory of Clinical Neurophysiology, Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo SP Brazil
    • Child Neurology Unit-University of São Paulo Medical School, São Paulo,Brazil
    • ,
  • Alessandra Freitas, M.D.

      Affiliations

    • Laboratory of Clinical Neurophysiology, Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo SP Brazil
    • ,
  • Lia A Fiore, M.D.

      Affiliations

    • Laboratory of Clinical Neurophysiology, Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo SP Brazil
    • ,
  • Kette D Valente, M.D., Ph.D

      Affiliations

    • Laboratory of Clinical Neurophysiology, Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo SP Brazil
    • Corresponding Author InformationCommunications should be addressed to: Dr. Valente; Laboratory of Clinical Neurophysiology; R. Jesuíno Arruda, 901 Apt. 51; 04532 082 São Paulo SP Brazil.

Received 5 September 2002 ,Accepted 10 December 2002.

References 

  1. Cramer JA, Fisher R, Bem-Menachem E, French J, Mattson RH. New antiepileptic drug (Comparison of key clinical trials). Epilepsia. 1999;40:590–600
  2. Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO. Interaction of lamotrigine with sodium valproate. Lancet. 1993;341:445; [Letter]
  3. Pisani F, Russo M, Trio R. Efficacia dell’associazione lamotrigina-valproato di sódio nelle crisi epilettiche parziali resistenti. Q Acta Neurol. 1992;58:71–73
  4. Pisani F, Di Perri R, Perucca E, Richens A. Interaction of lamotrigine with sodium valproate. Lancet. 1993;341:1224; [Comment Letter]
  5. Brodie MJ, Yuen AWC  105 Group Study . Lamotrigine substitution study (Evidence for synergism with sodium valproate). Epilepsy Res. 1997;26:423–432
  6. Yuen AWC, Land G, Wetherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol. 1992;33:511–513
  7. Morris RG, Black AB, Lam E, Westley IS. Clinical study of lamotrigine and valproic acid in patients with epilepsy (Using a drug interation to advantage?). Therapeutic Drug Monitor. 2000;22:656–660
  8. Kanner AM, Frey M. Adding valproate to lamotrigine (A study of their pharmacokinetic interaction). Neurology. 2000;55:588–591
  9. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures (Evidence for a pharmacodynamic interaction). Clin Res. 1999;40:1141–1146
  10. Guberman AH, Besag FMC, Brodie MJ. Lamotrigine-associated rash: Risk/benefit considerations in adults and children. Epilepsia. 1999;40:985–991
  11. Duchowny M, Pellock JM, Graf WD. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology. 1999;53:1724–1731
  12. McCabe PH, Michel NC, McNew CD. Clinical efficacy of combination therapy with valproic acid and lamotrigine in intractable epilepsy. Epilepsia. 1998;39(Suppl 6):49
  13. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand. 1995;91:200–202
  14. McCabe PH, McNew CD, Michel NC. Effect of divalproex-lamotrigine combination therapy in frontal lobe seizures. Arch Neurol. 2000;58:1264–1268
  15. Ramaratnam S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant epilepsy. Cochrane Database Syst Rev. 2000;3:CD001909
  16. Messenheimer JA, Giorgi L, Risner ME. The tolerability of lamotrigine in children. Drug Safety. 2000;22:303–312
  17. Besag FMC. Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research. 1998;42(Suppl 1):50–56
  18. Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barret PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001;56:172–177
  19. Ettinger AB, Weisbrot DM, Saracco J, Dhoon A, Kanner A, Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia. 1998;39:874–877
  20. Gidal BE, Anderson GD, Rutecki PR, Shaw R, Lanning A. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epil Res. 2000;42:23–31
  21. Matsuo F. Lamotrigine. Epilepsia. 1999;40(Suppl. 5):S30–S36

PII: S0887-8994(03)00014-6

doi: 10.1016/S0887-8994(03)00014-6

Pediatric Neurology
Volume 28, Issue 5 , Pages 360-364 , May 2003

Article Tools